Inhibition of Cyclin-dependent Kinase (CDK) Decreased Survival of NB4 Leukemic Cells: Proposing a p53-Independent Sensitivity of Leukemic Cells to Multi-CDKs Inhibitor AT7519

An unbounded number of events exist beneath the intricacy of each particular hematologic malignancy, prompting the tumor cells into an unrestrained proliferation and invasion. Aberrant expression of cyclin-dependent kinases (CDKs) is one of these events which disrupts the regulation of cell cycle an...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Iran J Pharm Res
Päätekijät: Pourbagheri-Sigaroodi, Atieh, Safaroghli-Azar, Ava, Shanaki, Mehrnoosh, Yousefi, Amir-Mohammad, Anjam Najmedini, Ali, Bashash, Davood
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Shaheed Beheshti University of Medical Sciences 2020
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7758003/
https://ncbi.nlm.nih.gov/pubmed/33680018
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22037/ijpr.2020.113170.14148
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia